查詢結果分析
來源資料
相關文獻
- Successful Treatment of Adult Type Granulosa Cell Tumor of the Ovary--A Case Report and the Literature Review
- 早發性卵巢衰竭
- Concomitant Measurement of CA 125 and CA19-9 in Detecting Ovarian Malignancy: A Review Study of 64 Cases
- Obturator Mononeuropathy: A Rare Clinical Presentation of Ovarian Cancer
- A Huge Ovarian Solid Tumor with Massive Ascites: A Case Report
- Clinical Pitfall of Aspiration Cytology in Differential Diagnosis of an Adnexal Mass Complicating Pregnancy: A Case Report
- 雙側卵巢Krukenberg腫瘤之皮膚轉移
- 卵巢過度刺激症候群
- 卵巢功能不良之評估與治療對策
- 河車大造丸對兩側卵巢切除後老鼠雌激素的影響
頁籤選單縮合
題 名 | Successful Treatment of Adult Type Granulosa Cell Tumor of the Ovary--A Case Report and the Literature Review=成功治療成人型卵巢顆粒層細胞瘤--病例報告與文獻回顧 |
---|---|
作 者 | 簡佑安; 張東浩; 劉幕台; 畢祖平; 黃家俊; 洪儷中; 周采薇; | 書刊名 | 放射治療與腫瘤學 |
卷 期 | 22:1 2015.03[民104.03] |
頁 次 | 頁83-88 |
分類號 | 417.25 |
關鍵詞 | 成人型; 顆粒層細胞瘤; 卵巢; Adult type; Granulosa cell tumor; Ovary; |
語 文 | 英文(English) |
中文摘要 | 前言:卵巢顆粒層細胞瘤在分類上屬於性索間質細胞,約佔卵巢腫瘤的2-5%。其中成人型佔卵巢顆粒層細胞瘤的95%之多,好發在50到55歲的女性。腫瘤分期是卵巢顆粒層細胞瘤最重要的預後因子,第一期的十年整體存活率為84-95%,第二期為50-65%,第三及第四期為0-22%。病例報告:一個56歲的女性,因為左側卵巢顆粒層細胞瘤在臨床分期至少有第三期,所以於西元2002年2月23日接受減積手術。術後,她接受以撲累惡注射劑(Bleomycin)、順鉑(Cisplatin)與依托泊甙(Etoposide)為處方的輔助性化學治療共四個療程。接著接受輔助性全腹腔骨盆腔放射線治療21次,劑量為25.2 Gy。完成之後,再接受骨盆腔放射線治療11次,劑量為19.8 Gy。自結束療程至今,她都規則在本院追蹤,且沒有任何腫瘤復發或疾病繼續進展的現象。討論:至今對於患有卵巢顆粒層細胞瘤的病人仍然沒有標準和公認明確有效的治療方法,特別是第三四期,或是復發以後無法開刀的患者。面對這個疾病,通常手術切除是第一線的治療方式。在化學治療方面,以順鉑為主的處方選擇至今也未能有清楚的指引。輔助性放射線治療的角色也沒有確定。近期,有一篇研究指出輔助性放射線治療有助於治療卵巢顆粒層細胞瘤。有另一篇研究指出緩和性放射線治療對緩解病人的症狀有正面的幫助。因此,我們建議在特定的卵巢顆粒層細胞瘤患者上,輔助性放射線治療應可改善預後。 |
英文摘要 | Introduction: Granulosa cell tumor (GCT) of the ovary is classified as a sex cord stromal tumor, representing approximately 2-5% of ovarian neoplasms, and adult type accounts 95% of all GCTs, usually occurs in women during 50-55 years old. The most important prognostic factor of this tumor is stage, with 10-year overall survival of 84-95% for stage I tumors, decreasing to 50-65% for stage II tumors, and to 0-22% for stage III and IV disease. Case report: A 56-year-old woman with left side ovarian granulosa cell tumor, at least clinical FIGO stage IIIa, underwent debulking operation on February 23rd, 2002. After surgery, she received four cycles adjuvant chemotherapy with the regimen of Bleomycin, Cisplatin and Etoposide. Then she received postoperative whole-abdomen and pelvis irradiation. The dose was given 2520 cGy in 21 fractions with liver and kidney shielding. After whole-abdomen and pelvis irradiation, she received pelvis boost with the dose of 1980 cGy in 11 fractions. Since then, she was regularly followed at our hospital until now without any signs of tumor recurrence nor tumor progression. Discussion: Until now there is no standard and proven treatment for GCT patients, especially when they suffered from advanced-stage or recurrent unresectable tumors. Complete tumor resection should be considered as the primary treatment. The optimal choice of combination platinum-based chemotherapy is still not well-defined. The role of adjuvant radiation therapy remains controversial. We suggested that adjuvant RT for patients with GCT might improve outcomes in selected patients. |
本系統中英文摘要資訊取自各篇刊載內容。